Industry News
Garvan reaps surprise windfall
The Garvan Institute celebrated 40 years of sharp end research into cancer and associated diseases last week -- and in the process gained over $1million in research funds. [ + ]
Queensland BioCapital Fund announces first investment
Queensland Premier Peter Beattie has opened his campaign to grab a slice of the spotlight for the State during Bio2003 by announcing the first investment by Australia’s largest biotechnology fund, the $100 million Queensland BioCapital Fund. [ + ]
NSW pledges $205 million for new Institute
The NSW government has taken the first step towards fulfilling its election pledge, with $205million on the table over the next four years as funding for the new peak cancer research organsation. [ + ]
AGT Biosciences opens up in Texas
Victorian company AGT Biosciences (formerly Autogen) has opened its AGT Biosciences Center for Human Statistical Genomics at the Southwest Foundation for Biomedical Research in San Antonio, Texas. [ + ]
Norwood Abbey planning clinical trial
Norwood Abbey is in the midst of planning an international clinical trial examining the use of its Gonadotropin Releasing Hormone (GnRH) analogue drugs to revive the immune system in patients with HIV/AIDS. [ + ]
Technology management and transfer under the microscope
A renowned German technology marketing and commercialisation expert will be the coordinator and keynote speaker of a University of Adelaide technology course beginning later this month.
[ + ]PsiMedica enters revenue sharing agreement
Perth nanotechnology company PsiVida announced that its British subsidiary PsiMedica has entered into a revenue sharing agreement with Texas Christian University (TCU) over an invention with applications in orthopaedics and tissue engineering. [ + ]
Bio Pharma signs $3.5m contract
A $3.5 million dollar conditional contract with an Asian company could give startup Bio Pharma Pty Ltd the push it needs to move into commercial production. [ + ]
Peptech reports 'outstanding' results
Biotech Peptech announced what it described as "outstanding" results from pre-clinical trials on its anti-Tumour Necrosis Factor (anti-TNF) antibody as a treatment for rheumatoid arthritis (RA). [ + ]
Oz biotechs beat the bulls
Local biotech performers have overtaken the traditional basket of stocks by 13 per cent, showing a 27 per cent leap in prices, according to a report from stockbroking firm Intersuisse. [ + ]
Imugene completes $2m placement
Veterinary biotechnology company Imugene has completed a $AUD2 million placement to institutional and professional high net worth investors. [ + ]
Bacterial proteomics attracts grant
One of the biggest ARC Linkage Project grants in the recent round has been awarded to University of Sydney microbiologist, Dr Liz Harry, to work with Australian proteomics pioneers, Proteome Systems, on bacterial proteomics. [ + ]
Link found between birth weight and kidney health
A Monash University study has found that the number of nephrons in a person's kidney increases with their birth weight, a finding that could explain why Indigenous Australians and African-Americans are at greater risk of kidney disease and high blood pressure.
[ + ]Research teams receive $73m in latest NHMRC grants
More than $AUD73 million has been awarded to 11 research teams based in Victoria, New South Wales and Queensland in the latest round of the NHMRC's program grants. [ + ]
Genetic Technologies receives $US150,000 for patent license
Texan company Inguran has paid $US150,000 to Melbourne-based Genetic Technologies to use the company's non-coding patents for genetic testing of livestock in the USA, Colombia and Brazil. [ + ]